Follow today's market news in real time: CAC 40 prices, corporate announcements, financial releases and market information. This page automatically aggregates the latest briefs and press releases to give you the most up-to-date view of the moves driving the session.
Ieva Group, which went public on March 26, 2026, presents its first annual results as a listed company. The group shows a stark contrast: a dynamic of external …
On April 7, 2026, the board of directors of Emeis decided to propose Olivier Dussopt as the new chairman of the board and director, replacing Guillaume Pepy, to…
EMEIS confirms its exit from the safeguard plan by displaying a sharp operational rebound in 2025: EBITDAR increases by 19.2% on a like-for-like basis, nursing …
Fleury Michon reports a revenue increase of 3.6% to 836.4 million euros in 2025, supported by market share gains in mass retail and an acceleration of internati…
Alstom has won a signaling order in Europe valued at approximately €295 million. This order was recorded in the fourth quarter of the fiscal year 2025/26.
Arcure released its 2025 results, showing a significant drop in revenue to €12.6 million, due to its strategic shift towards OEM first-mount sales and a context…
This Wednesday, 9 listed companies have published or revealed their financial results and revenues. Here's an overview of the stocks to watch before the market …
JCDecaux SE has won the advertising concession bid for Western Sydney International (WSI), the new 24-hour Sydney airport. This long-term contract allows the gr…
ENGIE announces the acquisition of two battery energy storage projects in Spain and the commencement of construction on its first such system in France. These i…
DMS Group announces the acquisition of the MDR (Medical Device Regulation) certification for its entire range of STRATOS and STRATOS DR bone densitometers. This…
Euronext plans to distribute an annual dividend of €3.18 per share for the fiscal year 2025, pending shareholder approval at the general meeting on May 20, 2026…
Shares of the Nantes-based vaccine specialist experienced a sharp decline on Tuesday, April 7, trading at 2.566 euros at the end of the session. This drop exten…
On Tuesday, April 7, the stock of the biotech company specializing in food allergies saw a sharp decline in a generally downward Parisian market. With a price a…
DISCLAIMER: This information is not contractual in nature and carries no guarantee of accuracy. It should not be considered investment advice. Ideal-investisseur.fr cannot be held liable for any damages or losses arising from the use of this information.
